Söndag 27 April | 11:33:00 Europe / Stockholm

Bifogade filer

Prenumeration

Kalender

Est. tid*
2025-10-24 08:30 Kvartalsrapport 2025-Q3
2025-08-29 08:30 Kvartalsrapport 2025-Q2
2025-05-26 N/A X-dag ordinarie utdelning HELIO 0.00 SEK
2025-05-25 N/A Årsstämma
2025-04-25 - Kvartalsrapport 2025-Q1
2025-02-28 - Bokslutskommuniké 2024
2025-02-12 - Extra Bolagsstämma 2025
2024-10-25 - Kvartalsrapport 2024-Q3
2024-08-23 - Kvartalsrapport 2024-Q2
2024-06-05 - Årsstämma
2024-05-03 - X-dag ordinarie utdelning HELIO 0.00 SEK
2024-05-03 - Kvartalsrapport 2024-Q1
2024-02-23 - Bokslutskommuniké 2023
2023-10-27 - Kvartalsrapport 2023-Q3
2023-08-25 - Kvartalsrapport 2023-Q2
2023-05-05 - X-dag ordinarie utdelning HELIO 0.00 SEK
2023-05-03 - Årsstämma
2023-04-28 - Kvartalsrapport 2023-Q1
2023-03-01 - Bokslutskommuniké 2022
2022-10-21 - Kvartalsrapport 2022-Q3
2022-08-19 - Kvartalsrapport 2022-Q2
2022-05-23 - X-dag ordinarie utdelning HELIO 0.00 SEK
2022-05-22 - Årsstämma
2022-04-22 - Kvartalsrapport 2022-Q1
2022-02-25 - Bokslutskommuniké 2021
2021-10-22 - Kvartalsrapport 2021-Q3
2021-08-20 - Kvartalsrapport 2021-Q2
2021-05-21 - X-dag ordinarie utdelning HELIO 0.00 SEK
2021-05-20 - Årsstämma
2021-04-23 - Kvartalsrapport 2021-Q1
2021-02-19 - Bokslutskommuniké 2020
2020-10-27 - Extra Bolagsstämma 2020
2020-10-27 - Kvartalsrapport 2020-Q3
2020-08-21 - Kvartalsrapport 2020-Q2
2020-05-15 - X-dag ordinarie utdelning HELIO 0.00 SEK
2020-05-14 - Årsstämma
2020-04-24 - Kvartalsrapport 2020-Q1
2020-02-21 - Bokslutskommuniké 2019
2019-10-25 - Kvartalsrapport 2019-Q3
2019-08-23 - Kvartalsrapport 2019-Q2
2019-06-27 - Årsstämma
2019-06-14 - X-dag ordinarie utdelning HELIO 0.00 SEK
2019-04-26 - Kvartalsrapport 2019-Q1
2019-02-22 - Bokslutskommuniké 2018
2018-10-26 - Kvartalsrapport 2018-Q3
2018-08-24 - Kvartalsrapport 2018-Q2
2018-06-15 - X-dag ordinarie utdelning HELIO 0.00 SEK
2018-06-14 - Årsstämma
2018-04-27 - Kvartalsrapport 2018-Q1
2018-02-23 - Bokslutskommuniké 2017
2017-10-27 - Kvartalsrapport 2017-Q3
2017-08-25 - Kvartalsrapport 2017-Q2
2017-06-15 - X-dag ordinarie utdelning HELIO 0.00 SEK
2017-06-14 - Årsstämma
2017-04-28 - Kvartalsrapport 2017-Q1
2017-02-24 - Bokslutskommuniké 2016
2016-11-08 - Extra Bolagsstämma 2016
2016-10-28 - Kvartalsrapport 2016-Q3
2016-08-26 - Kvartalsrapport 2016-Q2
2016-06-15 - X-dag ordinarie utdelning HELIO 0.00 SEK
2016-06-14 - Årsstämma
2016-04-29 - Kvartalsrapport 2016-Q1
2016-02-26 - Bokslutskommuniké 2015
2015-10-26 - Kvartalsrapport 2015-Q3
2015-08-31 - Kvartalsrapport 2015-Q2
2015-06-08 - X-dag ordinarie utdelning HELIO 0.00 SEK
2015-06-05 - Årsstämma
2015-04-30 - Kvartalsrapport 2015-Q1
2015-02-26 - Bokslutskommuniké 2014
2014-10-24 - Kvartalsrapport 2014-Q3
2014-08-29 - Kvartalsrapport 2014-Q2

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorIndustri
IndustriIndustriprodukter
Heliospectra är ett industriellt bolag specialiserade inom elektronik. Bolaget utvecklar kompletta belysningssystem för växthusmarknaden. Tekniken baseras på LED teknologi och erbjuds med tillhörande digitala lösningar, där kunderna kan styra belysningen via egenutvecklade mjukvaruplattformar. Största marknaderna för bolagets produkter återfinns inom Europa och Nordamerika. Huvudkontoret ligger i Göteborg.
2025-03-07 09:25:00
(GOTHENBURG, Sweden, Mar 7, 2025, at 09:25 CET) – Heliospectra AB (publ) ("Heliospectra" or the "Company") announces today, 7 March 2025, the outcome of the rights issue of shares amounting to a maximum of approximately SEK 25.6 million, which the Board of Directors resolved on January 23, 2025, and the extraordinary general meeting approved on February 12, 2025 ("Rights Issue"). The subscription period for the Rights Issue ended on March 5, 2025. The outcome shows that 77,925,698 shares, corresponding to approximately 63.85 percent of the Rights Issue, were subscribed for with the support of subscription rights. Additionally, subscription applications for 6,668,860 shares, corresponding to approximately 5.46 percent of the Rights Issue, were received for subscription of shares without the support of subscription rights. Together, the subscriptions with the support of subscription rights and subscription applications without the support of subscription rights constitute approximately 69.32 percent of the Rights Issue. Hence, the guarantee commitment will be utilised for the remaining 37,443,027 shares in the Rights Issue, corresponding to approximately 30.68 percent of the Rights Issue. The Rights Issue thus has a subscription rate of 100 percent and will provide the Company with proceeds of approximately 25.6 MSEK before deduction of issue costs and set-off of loan.

The Board of Directors resolved on January 23, 2025, subject to the approval of an extraordinary general meeting, to carry out a new share issue of up to approximately SEK 25.6 million with preferential rights for existing shareholders. The extraordinary general meeting on February 12, 2025, resolved to approve the Board of Director's decision on the Rights Issue. The subscription price in the Rights Issue was SEK 0.21 per share, and the subscription period for the Rights Issue lasted until March 5, 2025.

Outcome of the Rights Issue

The Rights Issue amounted to a maximum of 122,037,585 shares, corresponding to approximately SEK 25.6 million. The outcome shows that 77,925,698 shares, corresponding to approximately 63.85 percent of the Rights Issue, were subscribed for with the support of subscription rights. Additionally, applications for the subscription of 6,668,860 shares without the support of subscription rights, corresponding to approximately 5.46 percent, have been received. Thus, the outcome shows that the Rights Issue, with and without the support of subscription rights, was subscribed to approximately 69.32 percent. This means that the guarantee commitment from Weland Stål AB (“Weland”) will be utilised for the remaining 37,443,027 shares, corresponding to 30.68 percent of the Rights Issue. Hence, a total of 122,037,585 shares are subscribed for, corresponding to 100 percent of the Rights Issue. The Rights Issue will provide Heliospectra with proceeds of approximately 25.6 MSEK before deduction of issue costs and set-off of loan.

The Board of Directors has resolved to approve that Weland set-off loan claims against the Company, arising from the loan of SEK 10 million the Company raised in January 2025, as payment for the shares allotted and subscribed for pursuant to Weland’s guarantee commitment.

Notification of Allocation

Those who have subscribed for shares without the support of subscription rights will be allocated shares in accordance with the principles set out in the information memorandum published by the Company on February 20, 2025. Notification of any allocation of shares, subscribed for without the support of subscription rights, will be provided by sending an allocation notice in the form of a transaction note, which is expected to be sent out as soon as possible. Subscribed and allocated shares must be paid for in cash in accordance with the instructions on the transaction note. Investors who have subscribed through a nominee will receive notification of allocation in accordance with their respective nominee's procedures. Only those who have been allocated shares will be notified.

Trading in paid subscribed shares (BTA)

Trading in paid subscribed shares (BTA) will take place on Nasdaq First North Growth Market until the Rights Issue has been registered with the Swedish Companies Registration Office, which is expected to occur in week 12, 2025.

Shares and share capital

Through the Rights Issue, the number of shares in Heliospectra will increase by 122,037,585 shares, from 122,037,585 shares to 244,075,170 shares, and the share capital will increase by 500,000 SEK, from 500,000 SEK to 1,000,000 SEK. For existing shareholders who do not participate in the Rights Issue, this will result in a dilution effect of 50.00 percent of the total number of shares and votes in the Company.

Advisers

MAQS Advokatbyrå AB is legal adviser to the Company in connection with the Rights Issue and Aqurat Fondkommission AB is issuing agent in the Rights Issue.